Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GES
2226
DELISTED
Guess Inc
GES
| $5.99M | ﹤0.01% |
619,862
+12,721
| +2% | +$112K |
|
|
KE
2227
Kimball Electronics
KE
$651M
| $5.99M | ﹤0.01% |
442,340
+8,471
| +2% | +$109K |
|
2228
Kiniksa Pharmaceuticals
KNSA
$6.01B
| $5.99M | ﹤0.01% |
234,986
+30,837
| +15% | +$644K |
|
2229
ProPetro Holding
PUMP
$1.36B
| $5.96M | ﹤0.01% |
1,160,684
+25,750
| +2% | +$119K |
|
|
VRS
2230
DELISTED
Verso Corporation
VRS
| $5.95M | ﹤0.01% |
497,566
+12,545
| +3% | +$164K |
|
2231
Powell Industries
POWL
$7.8B
| $5.94M | ﹤0.01% |
650,748
-1,101
| -0.2% | -$9.36K |
|
|
DHIL
2232
DELISTED
Diamond Hill
DHIL
| $5.93M | ﹤0.01% |
52,166
+228
| +0.4% | +$23.9K |
|
|
USCR
2233
DELISTED
U S Concrete, Inc.
USCR
| $5.93M | ﹤0.01% |
239,062
+9,142
| +4% | +$183K |
|
|
EB
2234
DELISTED
Eventbrite
EB
| $5.92M | ﹤0.01% |
691,286
+185,925
| +37% | +$1.64M |
|
|
LGF.A
2235
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $5.92M | ﹤0.01% |
798,592
+37,147
| +5% | +$275K |
|
2236
CytomX Therapeutics
CTMX
$721M
| $5.91M | ﹤0.01% |
708,889
+3,702
| +0.5% | +$34.4K |
|
2237
Beam Therapeutics
BEAM
$2.82B
| $5.89M | ﹤0.01% |
210,529
+138,963
| +194% | +$2.99M |
|
|
SHOE
2238
Shoe Station Group
SHOE
$420M
| $5.88M | ﹤0.01% |
401,706
+7,118
| +2% | +$85.1K |
|
2239
A10 Networks
ATEN
$2.2B
| $5.88M | ﹤0.01% |
863,154
+95,869
| +12% | +$644K |
|
2240
Phathom Pharmaceuticals
PHAT
$688M
| $5.87M | ﹤0.01% |
178,342
+17,415
| +11% | +$669K |
|
2241
VirnetX Holding Corp
VHC
$59.4M
| $5.85M | ﹤0.01% |
44,978
+1,994
| +5% | +$244K |
|
2242
SM Energy
SM
$7.16B
| $5.85M | ﹤0.01% |
1,559,031
+14,639
| +0.9% | +$47.9K |
|
|
BZUN
2243
Baozun
BZUN
$172M
| $5.83M | ﹤0.01% |
152,486
-85
| -0.1% | -$2.67K |
|
|
FLIC
2244
DELISTED
First of Long Island Corp
FLIC
| $5.82M | ﹤0.01% |
356,474
+9,856
| +3% | +$151K |
|
2245
Ryanair
RYAAY
$31.9B
| $5.82M | ﹤0.01% |
219,370
-4,888
| -2% | -$124K |
|
|
BSTC
2246
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $5.81M | ﹤0.01% |
94,760
+617
| +0.7% | +$35.7K |
|
2247
Mitek Systems
MITK
$793M
| $5.8M | ﹤0.01% |
604,068
-5,797
| -1% | -$52.3K |
|
2248
Liberty Latin America Class A
LILA
$1.67B
| $5.8M | ﹤0.01% |
932,423
+43,107
| +5% | +$283K |
|
2249
Omega Flex
OFLX
$305M
| $5.8M | ﹤0.01% |
54,783
+2,063
| +4% | +$196K |
|
2250
PAR Technology
PAR
$721M
| $5.78M | ﹤0.01% |
193,185
+35,839
| +23% | +$784K |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.